Democrats are facing a daunting stretch as the party struggles to get beyond internal battles to win approval of President Biden’s agenda — and deal with other crises that have effectively been punted to the Christmas season.
Democrats are entering the home stretch of the year with four big priorities: funding the government, raising the debt ceiling and passing both the bipartisan infrastructure bill and a sweeping social spending measure.
It’s a stretch that could make or break Biden’s agenda and will surely set up battles for next year’s midterm elections.
“There’s a lot of stress being felt, or a lot of things at stake in terms of causes that many of us fought for, for a lifetime,” Sen. Dick Durbin (Ill.), the No. 2 Senate Democrat, said about the current dynamic within the caucus.
The tensions between Democrats — including moderates versus progressives, the Senate versus the House and moderates versus leadership — are increasingly boiling over. That includes a days-long shadowboxing match between Senate Budget Committee Chairman Bernie Sanders (I-Vt.) and centrist Sen. Joe Manchin (D-W.Va.) over Biden’s social spending measure.
Manchin and Sanders have spent days trading criticisms through the press, but Sanders brushed off a question about if they or Sen. Kyrsten Sinema (D-Ariz.), another moderate Sanders has urged to be more specific, should get in the room together to hash things out.
“This is not a movie,” Sanders said. “When you’ve got 48 people on one side … it is simply not fair, not right, that one or two people say my way or the highway.”
Sanders and progressives disagree with Manchin, Sinema and House centrists over the measure’s policy details and size.
Sanders is refusing to acknowledge a price tag below $3.5 trillion, while Congressional Progressive Caucus Chairwoman Pramila Jayapal (D-Wash.) is pushing for a bill around $3 trillion. That’s significantly higher than Manchin’s top line of $1.5 trillion or the roughly $2 trillion range floated by the White House.
The bipartisan infrastructure bill already passed by the Senate, progressives say, won’t move through the House without passage of the larger spending bill. But that’s left moderates fuming.
Moderate Rep. Jared Golden (D-Maine) said some of his constituents are “sick of the bickering” and want Congress to “stop fighting and sort it out.”
“I strongly support the bipartisan infrastructure bill and think the House should pass and send it to the president immediately. As for the separate $3.5 trillion draft reconciliation proposal in the House … I cannot support it in its current form, nor does it currently have the votes to pass in Congress,” Golden wrote in a Portland Press Herald op-ed.
Democrats face tough choices if they have to lower the size of the bill, as is likely.
Durbin, acknowledging that reality, urged Democrats to settle on a number, adding that “the sooner we get this done, the better. Everyone’s not going to win at the end of the day.”
They had hoped to fund everything from combating climate change to immigration reform as well as housing, child care, education assistance and a health care expansion.
But as the top line slips, they’ll need to think about investing heavily in a smaller number of programs or keeping their expansive wish list but taking more incremental approaches across the board.
While Democratic leadership is aiming to have the bill to Biden by the end of October, senators acknowledge they aren’t married to a timeline.
“Obviously we want to get it done as quickly as possible. But obviously this is an enormously complicated and consequential bill. … This is not a baseball game,” Sanders said, asked if the deal to put the debt ceiling put pressure on Democrats to get the social spending bill done quickly.
But they also can’t risk it dragging too far into fall. If they can’t pass the bipartisan infrastructure bill by the end of October, they’ll need to pass another short-term highways extension, and the scheduling of other must-pass bills, including an annual defense policy bill, have also been in limbo as Democrats try to figure out when they’ll bring their two-part spending package to the floor.
They also risk running directly into round two of their fight over the debt ceiling and funding the government.
Government funding is set to run out on Dec. 3, setting a hard deadline for lawmakers to prevent a shutdown heading into the holidays. And the Treasury estimates that the $480 billion debt hike — which is expected to pass the House on Tuesday — will extend the nation’s borrowing limit until roughly the same time.
When exactly the debt ceiling will hit is unclear. The Bipartisan Policy Center’s Shai Akabas noted that analysts are trying to estimate how much money is going into and out of the government and that the “uncertainty comes on the back end” of the Dec. 3 timeline.
Both sides are already digging in.
Senate Majority Leader Charles Schumer (D-N.Y.) is doubling down on his pledge that Democrats won’t use reconciliation — a budget process that lets them bypass the 60-vote legislative filibuster — to pass a long-term debt hike later this year. The votes are tough politically for Democrats because they have to raise the debt ceiling to a number instead of suspending it to a date.
“The solution is for Republicans to either join us in raising the debt limit or stay out of the way and let Democrats address the debt limit ourselves,” Schumer said. “Senate Democrats want a long-term solution. … I hope my Republican colleagues relent from trying to make it one when we revisit this issue soon.”
While 11 Republicans helped Senate Democrats overcome a key procedural hurdle on the debt ceiling last week, they are vowing they won’t do so again.
The move, GOP senators argue, was designed to take pressure off changes to the filibuster and prove Democrats had time to raise the debt ceiling on their own under the budget rules. Schumer also rankled the GOP senators he’ll need in December with a fiery speech he gave just before the Senate passed the short-term debt hike.
Senate Minority Leader Mitch McConnell (R-Ky.) — who has faced criticism from his own members for proposing the short-term debt hike — vowed in a phone call and letter to Biden that Republicans will not help raise the debt ceiling in December. He also railed against Schumer’s speech, saying the Democratic senator’s “tantrum” had “poisoned the well” with GOP senators.
“Your lieutenants on Capitol Hill now have the time they claimed they lacked to address the debt ceiling through standalone reconciliation. … They cannot invent another crisis and ask for my help,” McConnell wrote.
If Republicans don’t blink, congressional Democrats will have limited options, and it could lead to pressure on Manchin and Sinema to create a carveout from the legislative filibuster.
But asked about the looming end-of-year showdown, Manchin said that creating a carveout from the filibuster is already off the table for him.
“The filibuster is the only thread that we have to keep democracy alive and well in America. It keeps us the body that we are,” Manchin said. “If we didn’t have the filibuster to where it would keep us keeping back to civility from time to time, then you would see total chaos.”
Reps. Diana DeGette (D-CO) and Fred Upton (R-MI) say swift passage of their Cures 2.0 bill that would authorize a new federal biomedical research agency is critical now that key Senate Democrats reportedly stripped from the reconciliation bill a provision providing $3 billion for President Joe Biden’s proposed Advanced Research Projects Agency for Health.
The deleted reconciliation language also would have given ARPA-H “other transactions authority” (OTA), which the Congressional Research Service warned could have posed intellectual property issues for medical products developed through ARPA-H.
House Energy & Commerce Committee Democrats had included $3 billion for ARPA-H in their portion of the lower chamber’s proposed Build Back Better Act — a broad $3.5 trillion partisan reconciliation package that Democrats are struggling to scale back to around $2 trillion to get support from hold-out moderates.
On Friday (Oct. 8), reports emerged that senators had deleted the $3 billion ARPA-H funding language from the package.
According to Politico, Senate health committee Chair Patty Murray (D-WA) said the proposed agency needs to be authorized before it can be funded.
Ellie Dehoney, vice president of policy and advocacy for Research!America, asserted Murray’s team also didn’t think there were dollars within the committee to pay for ARPA-H, and wanted to focus on more bipartisan, bicameral work.
E&C’s $3 billion would have supplemented the $3 billion for ARPA-H that was included in the House-passed appropriations minibus in July, which would have brought the total amount for ARPA-H to $6 billion, much closer to Biden’s $6.5 billion funding request.
But any proposed funding is contingent on Congress passing legislation to establish the agency. Lawmakers did not include authorizing language in the reconciliation bill because it would have violated the Byrd rule, Upton said during an E&C reconciliation bill markup in September. The rule prohibits the Senate from considering extraneous matters as part of a reconciliation package.
Upton and DeGette previously acknowledged that the language in the reconciliation bill wasn’t perfect or as robust as it needed to be to get ARPA-H up and running. There are a number of things E&C needs to do to improve the language, but that wasn’t possible to do in reconciliation because of the Byrd rule, Upton added.
DeGette and Upton plan to include language to authorize ARPA-H in their emerging Cures 2.0 bill, which they recently said they hope to get passed by year’s end. Upton and DeGette released the draft version of Cures 2.0 in June and plan to officially introduce the bill in the coming weeks, the lawmakers said in a statement on Friday.
The news that ARPA-H funding language has been removed from reconciliation makes passages of Cures 2.0 even more important, the lawmakers said.
“Creating this new advanced research agency to cure some of the world’s most difficult diseases — such as cancer, Alzheimer’s, ALS and more — has been one of the Biden administration’s top priorities. And it’s why we have been working tirelessly for many months now to craft the language needed, not only to make ARPA-H a reality but, to ensure its success as part of our Cures 2.0 bill — which we plan to introduce in the coming weeks,” the lawmakers said.
Despite the reported removal of the funding language, Dehoney told Inside Health Policy there’s still a path for ARPA-H. She doesn’t think it’s a setback, especially if Congress passes the $3 billion for ARPA-H that was included in the House-passed appropriations minibus in July.
“It’s a change but there’s a path. There’s a very strong path to getting it done this year, I think,” she told IHP.
A year-end omnibus spending bill could also include authorizing language for ARPA-H.
“It’s not unprecedented for omnibus bills to have authorizing language in them. And so one path is the December omnibus bill,” Dehoney said.
Lawmakers on both sides of the aisle have expressed support for ARPA-H but some also say there need to be more committee discussions and hearings around the proposal.
Dehoney expects several more ARPA-H-focused bills to be introduced, including another on the House side from E&C health subcommittee Chair Anna Eshoo (D-CA). Murray and Senate health committee ranking Republican Richard Burr (NC) will also have their own legislation.
Dehoney says ARPA-H’s positioning also will be a key focus: Will it reside inside the National Institutes of Health, alongside NIH or in HHS? Dehoney said she wouldn’t be surprised if Eshoo’s legislative proposal puts ARPA-H inside of HHS.
Hiring authorities also need to be addressed, Dehoney said.
CRS also pegged IP as a potentially controversial issue that will need to be resolved.
The Biden administration has requested OTA for ARPA-H and that language was included in the E&C reconciliation provision.
OTA is an acquisition mechanism that does not fit into any of the traditional mechanisms used by the federal government for acquiring goods or services, such as contracts, grants or cooperative agreements, CRS explains in a Sept. 23 report. OTA is generally viewed as giving federal agencies additional flexibility to develop agreements tailored to the needs of the project and its participants, who do not have to comply with the government’s procurement regulations.
The government typically creates OTA to obtain leading-edge research and development or prototypes from commercial sources that are unwilling or unable to navigate the government’s procurement regulations, CRS says.
CRS asserts that OTA could end up being controversial in the context of medical products. A common justification for using OTA is that some companies might seek greater IP protections than are available under traditional federal funding mechanisms when deciding to work with ARPA-H.
In recent years, there has been increased interest in ensuring that medical products discovered with federal support are affordable, including by having the federal government exercise some of its IP rights to inventions developed with federal support. With those rights potentially waived in OTA authority, there might be some concern about the government’s ability to ensure that products developed with ARPA-H support are available and affordable commercially, CRS says.
Dehoney said there will need to be some discussions about IP. Those discussions can be pretty complex. The Defense Advanced Research Projects Agency and the Advanced Research Projects Agency-Energy have worked through IP issues, but it can be different for health products.
March-in is also a larger IP-related issue that’s going to have to be worked out no matter what, she added.
“It will be interesting to see how they talk about that, but I don’t see that as a deal breaker,” Dehoney said.
The Bayh-Dole Act allows federal agencies that fund private research to require patent holders to grant licenses to other companies to make patented products. The government has never used its so-called march-in power.
NIH is the primary agency to fund early research on drugs, but outgoing NIH Director Francis Collins has said the law only allows agencies to march in on patents when drugs are not available, and that power does not exist when the government wishes drugs were cheaper.
Collins recently announced he is stepping down after 12 years of running NIH, and Public Citizen and Knowledge Ecology International have said his retirement presents an opportunity to press the administration to use march-in rights to lower drug prices.
Reps. Diana DeGette and Fred Upton say swift passage of their Cures 2.0 bill that would authorize a new federal biomedical research agency is critical now that key Senate Democrats reportedly stripped from the reconciliation bill a provision providing $3 billion for President Joe Biden’s proposed Advanced Research Projects Agency for Health.
Allowing doctors and other providers to easily practice telemedicine across state lines would combat the nationwide health-care staffing shortage ignited by the Covid-19 pandemic.
“Workforce is an issue,” Deanna Larson, CEO at telemedicine provider Avel eCare, said at a Thursday hearing of a Senate Commerce, Science, and Transportation panel. Larson serves on the board of directors of the American Telemedicine Association. “It’s very important to us that geography is not limiting where we can see individual patients,” Larson said.
The health-care industry is facing a staffing crisis due to the increasing demand of caring for Covid-19 patients, pandemic-induced exhaustion, greater use of sick leave, and employees choosing to resign or getting fired over vaccine mandates. Hospitals are paying inflated wages to meet patient demand, burdening an already drained industry.
There’s also the “twin crisis” of having both “an aging population, and an aging workforce that’s diminishing trying to care for it,” Kyle Zebley, the American Telemedicine Association’s vice president of public policy, said in an interview.
Some states have “virtually no mental health providers or specialists in certain areas,” Zebley said. “Obviously, having access to the rest of the nation’s health-care professionals would help improve access to care.”
Whether a provider can practice telehealth across state lines depends on both federal and state policies, according to the Health Resources and Services Administration, part of the U.S. Department of Health and Human Services.
Some states have agreements that allow for an expedited process for physicians to practice using a single license. Other states require providers to get a new license, which can be a time-consuming and expensive process, Mei Kwong, executive director of the Center for Connected Health Policy, said in an interview.
“Licensing is really a barrier,” and makes it harder for people in rural areas to see specialists like dermatologists, Larson said. Some states require physicians to be fingerprinted on site, which can be difficult for a busy physician.
Physicians could be likely to get multiple licenses if they live close to a border, Kwong said. But, for “one patient who lives in Florida,” it’s less likely a provider would “go through that entire process,” Kwong said.
While many states eased restrictions during the pandemic, those accommodations are beginning to peel back, Zebley said. Practicing across state lines is a polarizing issue, and raises questions about how physicians should enforce “contentious practice of medicine issues like abortion, birth control, euthanasia, or prescription of marijuana,” Zebley said.
Being able to access health-care remotely “is a matter of life and death,” Sen. Brian Schatz (D-Hawaii), said at the hearing.
Schatz is part of a group of 50 senators advocating for the CONNECT for Health Act (S. 1512), which would make permanent several of the telehealth flexibilities granted during the public health emergency, including removing geographic restrictions. The bill has bipartisan support.
The passage of the CARES Act last year enabled doctors and other medical providers to initiate telehealth care with a patient in their home. The Social Security Act generally keeps Medicare from reimbursing those visits unless they’re for patients in rural areas, or if they originate at a qualifying site like a hospital or nursing home.
Those exceptions will end when the public health emergency ends unless Congress takes action, leading to an approaching “telehealth cliff,” Schatz said.
If a patient still has to “get a ride and schlep some place, it defeats the purpose, at least partially, of telehealth in the first place,” Schatz said.
Telehealth also helps keep patients’ illnesses from escalating, Larson said.
“If we can’t immediately see an individual when they start to feel ill or have a situation going on, if we’re waiting, now that individual is probably going to be seen in an emergency department,” Larson said. “We can prevent much of that.”
The fight for provider relief continues as hospitals, nursing homes, practitioners, dentists and assisted living facilities, among others, vie for a piece of the phase 4 $25.5 billion distribution that HHS says will advance equity by rewarding medium and smaller providers with a special add-on relief payment.
HHS clarified in a webinar with providers that those receiving more than $10,000 in relief will be required to report any mergers with or acquisitions of another provider for audit purposes. The department also said that providers do not have to be in a rural area to qualify for part of the $8.5 billion in relief created under the American Rescue Plan in March, and that those receiving the rural relief cannot redistribute it to other providers in the same health care system.
The application period for the long-awaited fourth general distribution of provider relief opened Sept. 29, and providers will have through Oct. 26 to apply for $17 billion in general COVID-19 relief and $8.5 billion if they serve patients in rural areas.
Argentum held a webinar the same day the application period opened, encouraging its members, assisted living facilities, to apply early and submit as thorough of an application as possible.
“What we’re encouraging folks to do is — and [HHS] did specifically invite this — to really detail and explain your losses. Really set yourselves apart from other, different entities who, again, were not frontline caregivers,” Argentum Senior Vice President Maggie Elehwany said Sept. 29, suggesting members use the application’s addendum to make their case for relief.
Unlike previous relief payments that reimbursed providers up to 2% of patient revenue and 88% of revenue loss, phase 4 payments will be scaled to the provider’s size, which is based on their annual patient care revenue.
But HHS has yet to release the definitions for large, medium and small providers, Tom Barker from Foley Hoag LLP told Argentum members.
Most of the relief payment will be based off changes to providers’ operating revenues and expenses from July 1, 2020, to March 31, 2021. The agency in charge of distributing the $178 billion provider relief fund, the Health Resources and Services Administration, will give medium and smaller providers bonus payments calculated from their number of Medicare, Medicaid and CHIP beneficiaries; small providers will receive the highest supplement.
“HRSA will determine the exact percentage for the payments and supplements after analyzing data from all the applications received to ensure we remain within our budget and funds are distributed equitably,” reads HRSA’s slides from its webinars on Sept. 30 and Oct. 5.
Phase 4 relief has similar terms and conditions as previous distributions, like reporting requirements, but HRSA will now require providers receiving more than $10,000 in relief to tell the department of any mergers with or acquisitions of another provider.
“That’s the step we’re taking to help ensure that these funds are used for patient care,” HRSA staff said during the webinars. “Providers who do report a merger or acquisition may be more likely to be audited to confirm their funds were used for Coronavirus-related costs, consistent with an overall risk-based audit strategy.”
House Appropriations Committee Chair Rosa DeLauro (D-CT) and Rep. Katie Porter (D-CA) penned a letter to HHS and the Federal Trade Commission in May letter asking the departments to identify whether any CARES Act funds were used to engage in consolidation and/or fund potentially anticompetitive behavior.
HRSA also clarified that providers do not have to be in a rural area to qualify for part of the $8.5 billion in provider relief created under the American Rescue Plan in March. They just need to serve patients who live in rural areas — a fact HRSA will determine on its own.
The ARP rural relief has new restrictions that forbid providers from redistributing this relief to other providers in the same health care system. The American Hospital Association raised concerns with this restriction almost a year ago, arguing that it does not account for the fact that hospital systems function as an integrated coordinated whole in managing care and resources.
“I’m particularly pleased that the administration heeded my calls to set aside $8.5 billion for rural providers, including those in New Hampshire,” Sen. Jeanne Shaheen (D-NH) said in a statement Sept. 29. “These federal dollars can’t come soon enough to our hospitals, nursing homes and assisted living centers — this is a matter of life and death for patients across the country. I encourage providers to apply as soon as they can.”
Hospitals are paying $24 billion more for labor annually due to pandemic-driven staffing shortages and increased patient demand, draining resources when they’re already feeling the physical and emotional toll of the virus.
The $24 billion, according to data released Wednesday from health-care improvement company Premier Inc., represents an 8% increase in clinical labor costs per patient day compared with 2019.
Hospitals have had to pay nurses and other staff members inflated wages to keep their doors open amid nationwide staffing shortages, driven by burnout from an unrelenting virus, firings and resignations over vaccine mandates, and sickness and quarantine. Some states have even called in the National Guard to help meet patient demand during the delta variant’s surge.
Health-care providers are “just really at their wits end in terms of dealing with the pandemic,” said Doug Miller, vice president of workforce management operations at Premier.
The government issued funding to hospitals coping with lost revenues and pandemic-related expenses, but the health-care industry has said the more than $120 billion distributed isn’t enough to meet its needs.
Beyond increased staffing prices, hospitals are facing higher costs for drugs, supplies, preparation for more Covid-19 patients and their treatment, and the lost revenue from elective surgeries, American Hospital Association Executive Vice President Stacey Hughes wrote in a Wednesday letter to congressional leadership asking for legislative provisions that would provide financial relief.
The industry is also facing various regulatory burdens, from the reporting required of those that received pandemic assistance funds to demands that they list their prices for common services online.
“The COVID-19 pandemic has resulted in historic challenges for hospitals and health systems and the communities they serve, placing unprecedented stress on the entire health care system and its financing,” the letter said. The AHA is advocating against reducing Medicare payments so that providers can stay afloat.
The financial stress has led to a breaking point for some hospitals less able to weather the storm, with more than 40% of rural hospitals in the U.S. at immediate or high risk of closing in July 2021, according to a Center for Healthcare Quality and Payment Reform report.
The nursing industry was already facing labor shortages before the pandemic, said Beth Cloyd, principal consultant at Premier. The pandemic has tested nurses, who have worked longer hours in harder conditions, “but that resiliency and effort over time takes a toll on the workforce,” Cloyd said.
Hospitals may not be able to fill their vacancies any time soon, and the recent vaccine mandates could keep costs for labor high. So hospitals should look at bringing in international workers or consider how technology can help providers meet patient demand, Cloyd said. The Biden administration will speed up the visa process for health-care workers coming to the U.S. to aid in pandemic response.
Most of the evidence about how vaccine mandates will affect the workforce is anecdotal, Miller said, since many hospitals have not completed their vaccine mandate timelines. “I don’t know that anybody has a crystal ball to fully know how the data plays out,” Miller said, but Premier is working on another study to capture some of that evidence.
Premier used artificial intelligence to examine a workforce database and compare trends from October 2019 to August 2021. The study examines clinical employees who work in the emergency department, intensive care units, or nursing.
Among the survey’s other findings:
Copy of letter from AHA urging Congress to include provisions to extend the moratorium on Medicare sequester cuts and to prevent the Statutory Pay-As-You-Go Act of 2010 sequester from taking effect at the end of this session of Congress.
Long-term care facilities must fully explain predispute arbitration agreements to their residents if they want to continue getting paid by Medicare and Medicaid, as the requirement doesn’t conflict with federal arbitration laws, the Eighth Circuit said.
A U.S. Health and Human Services Department rule placing conditions on payments when nursing homes use such agreements isn’t preempted by the Federal Arbitration Act, is a valid exercise of the agency’s authority, and was adopted in compliance with federal administrative rules, the U.S. Court of Appeals for the Eighth Circuit said.
The rule doesn’t prohibit nursing homes from including predispute arbitration clauses in their residents’ contracts, the court said. This distinguishes it from a 2016 rule—blocked by a federal district court in Mississippi—that expressly banned facilities from requiring patients or their representatives to agree to arbitrate any disputes that arose while the patient was being treated there.
The district court in the Mississippi case found the 2016 rule inconsistent with the FAA.
Under the newer rule, nursing homes can continue to insist on such clauses, the court said. But they must fully explain what the arbitration clause means in the patient’s or representative’s language and make clear that admission and ongoing care aren’t dependent on their agreement in order to participate in the Medicare and Medicaid programs, it said.
HHS reasonably interpreted the Medicare and Medicaid laws to allow conditioning payments on the arbitration rule, the court said. The agency could reasonably conclude that predispute arbitration clauses could frustrate residents’ access to care “or jeopardize their health and well-being,” it said.
The rule is “a reasonable exercise” of the Centers for Medicare and Medicaid Services’ authority to protect residents’ rights, the court said.
The agency relied on sufficient evidence when adopting the rule, including “academic literature and court opinions” suggesting that predispute arbitration clauses are detrimental to residents’ health and safety, it said Oct. 1 in an opinion by Judge Jane Kelly.
The court affirmed summary judgment for HHS and CMS.
Chief Judge Lavenski R. Smith and Judge Ralph R. Erickson joined.
Kirkland & Ellis LLP and Hardin, Jesson and Terry PLC represent the nursing homes. The U.S. Department of Justice represents the government.
The case is Northport Health Servs. of Ark. v. U.S. Dep’t of Health & Human Servs., 2021 BL 375572, 8th Cir., No. 20-1799, 10/1/21.
The Biden administration released a rule Thursday that addresses one of the most fought-over provisions of a coming ban on surprise medical bills.
The rule details how a new class of medical billing arbiters will decide the fair price for emergency medical care, one of the largest sources of surprise bills. The rule received a positive reaction from consumer advocates and some legislators who drafted the law, but it “disappointed” emergency physicians, who fear it will lead to unreasonably low rates.
The ban on surprise medical bills was passed by Congress and signed into law by President Donald J. Trump last winter, but it is the Biden administration that has been fine-tuning the policy — amid intense lobbying from insurers, medical providers and advocates.
In a dispute between an insurer and a provider over an out-of-network bill, the rule directs the arbiters to focus first on the median price that other doctors and hospitals in the area have negotiated for that service.
This was the second major rule the Biden administration released on surprise billing this year, before the law takes effect in 2022. Taken together, the two regulations detail how the federal government will end what patients, academics and legislators often describe as one of the most exasperating practices in American medicine.
“We’re taking patients out of the middle of the food fight, and we’re also providing a clear road map on how you can resolve that food fight between the provider and the insurer,” said Xavier Becerra, secretary of Health and Human Services, in an interview.
Surprise medical bills happen when a doctor or other provider who isn’t in a patient’s insurance network is unexpectedly involved in a patient’s care. Patients may go to a hospital that accepts their insurance, for example, but get treatment from emergency room physicians or anesthesiologists who don’t — and who then send patients big bills directly.
Millions of Americans receive these type of bills each year. As many as one in five emergency room visits result in such a charge, and the rate of surprise billing is similar for women giving birth. Some coronavirus patients have received exceptionally high surprise bills. That includes a Pennsylvania woman who was unconscious and intubated when an out-of-network air ambulance transported her between hospitals. She was billed over $50,000 for the service.
Patients like that are essentially caught in the middle of a dispute between a doctor and an insurer, who disagree on the fair price for a given medical service. The new rule released Thursday lays out how newly hired billing arbiters will decide who, in those fights, is right.
Under the federal law, both the insurer and the doctor will tell an arbiter what they believe the appropriate price for the service should be. The arbiter will then look at a variety of factors to decide which of the two rates to pick.
The law that Congress passed has six factors the arbiters can consider. The rule released Thursday, however, directs the arbiters to focus on one of those factors as their starting point: the median prices that have been negotiated in the area for the same medical service.
The arbiter “must begin with the presumption” that this is “the appropriate out-of-network rate,” the rule states. They may consider other factors listed in the law, such as how sick the patient was or whether the hospital or doctor had made good faith efforts to join insurance networks, if they receive “credible information” from either party involved in the dispute on those subjects.
The administration on Thursday also opened applications for organizations to become arbiters. Applicants must have experience in “billing and coding” and “arbitration and claims management.”
The rules on how arbiters settle billing disputes are seen as especially important because they will determine whether the ban on surprise billing ultimately saves money for consumers, insurers and the federal government. The Congressional Budget Office estimated last year that the surprise billing ban would save the federal government $17 billion and reduce private insurance premiums 0.5 percent to 1 percent.
Most experts expect that starting from the in-network prices will ultimately lead to lower reimbursement rates. The Biden administration stated in the rule that the decision “will aid in reducing prices that may have been inflated due to the practice of surprise billing prior to the No Surprises Act.”
Trade groups representing health care providers, including emergency room physicians and hospitals, had generally urged the Biden administration to do something different: ensure that arbiters use all six of the factors listed in the law when they make up their minds. They argue that Congress intended for arbiters to have that broader deliberation, and that focusing on median in-network rates will lead to lower prices that are untenable.
“We’re pretty disappointed because this is entirely against congressional intent,” said Laura Wooster, senior vice president for advocacy at the American College of Emergency Physicians. “I’m not seeing how small physician groups will be able to work with this, and keep their doors open. Now is not the time to take away resources from emergency physicians.”
Congressional Democrats quickly applauded the new rule.
“Today’s rule implements the No Surprises Act just as we intended,” Senator Patty Murray of Washington and Representative Frank Pallone of New Jersey, who lead health committees in each of their chambers, said in a joint statement. “It establishes a fair payment resolution process between providers and insurers while finally taking patients out of the middle.”
Secretary Becerra said he expected the rule to generate “a lot of animated discussion on the part of the stakeholders in the industries” but felt the Biden administration had created a way to settle billing disputes that was straightforward and fair. “It will give patients some peace of mind that they don’t have to stand the chance of going bankrupt just because they had to go out of network,” he said.
Republican reaction to the rule wasn’t immediately available. Stakeholders are still reviewing the 521-page rule, and the administration will accept comments on it for the next 60 days. Given the relatively short timeline — the surprise billing ban is set to start in three months — major changes are not expected.
Hospitals reacted sharply toward a Biden administration regulation implementing legislation barring “surprise billing” of patients while health insurers and employers’ groups praised it for guarding against health-care price inflation.
The rule is a “windfall for insurers,” Stacey Hughes, executive vice president of the American Hospital Association, said. “The rule unfairly favors insurers to the detriment of hospitals and physicians who actually care for patients.”
Hughes made her remarks in a statement after four agencies on Thursday released an interim final rule (RIN 0938-AU62) that details the process for settling billing disputes between health-care providers and entities that pay the bills—health insurers and employers that sponsor employee health plans.
This is the most important regulation implementing the No Surprises Act that was enacted in 2020 as part of budget legislation (H.R. 133). It stipulates that arbitration awards in disputes must primarily be based on median in-network rates rather than giving providers more ammunition to argue that exceptional circumstances demand higher payments.
Under the law, patients can’t be billed by hospitals or medical providers for more than they would owe for in-network treatment in emergencies or in situations where an out-of-network clinician treats them during procedures performed at facilities that are in their networks. Such out-of-network treatment has often resulted in patients being billed for large amounts, sometimes in the tens of thousands of dollars.
“It’ll definitely be good for consumers,” Katie Keith, an associate research professor at Georgetown University, said in an interview. Keith co-authored an analysis of earlier surprise billing regulations.
“The Biden administration really made a strong statement about how it wants the federal IDR process to be used,” Keith said, referring to the independent dispute resolution process. “It does not want this to be a way for providers and facilities and air ambulances to stay out-of-network and think they’re going to be able to leverage this process for higher rates.”
The rule could result in more providers entering into network contracts with insurers, Keith said. “You could have consumers having increased access to in-network providers,” she said.
In addition, the rule will help prevent out-of-network care from inflating health-care costs, which could have an impact on premiums, Keith said.
In January, the Congressional Budget Office estimated that in most affected markets in most years, “smaller payments to some providers would reduce premiums by between 0.5 percent and 1 percent.”
“The biggest thing by far, when they talked about how the arbitration itself is going to work, the presumption is going to be the market-based qualified payment amount is a fair payment,” James Gelfand, executive vice president, public affairs, at the ERISA Industry Committee, said in an interview. ERIC represents large employers that provide health benefits.
The qualifying payment amount is the primary measure that will be used to determine rates in disputes under the rule. It’s based on a health plan’s historic median contract rate for similar services in a geographic area.
“There’s nothing more important than that that they could possibly have done,” Gelfand said. “It puts market dynamics at the center of this arbitration.”
In addition to setting the basis for deciding disputes rates, the rule also sets limits on the cost of arbitration, which has been worrisome, Gelfand said. Arbitration entities that must be certified by the federal government have to agree to reasonable fees, he said.
Hospitals and providers had wanted arbitration regulations not to be as dependent on the qualifying payment amount, which limits their payments.
They pointed to other factors that the No Surprises Act allows arbitrators to consider in billing disputes, such as the severity of a patient’s case and the experience of the provider.
“These consumer protections need to be implemented in the right way, and this misses the mark,” Hughes said.
The American Medical Association also objected strongly to the regulation.
“The interim final regulation issued late yesterday to implement the No Surprises Act ignores congressional intent and flies in the face of the Biden Administration’s stated concerns about consolidation in the health care marketplace,” AMA President Gerald Harmon said in a statement.
The AMA cited its study that found 73% of the nation’s insurer markets are “highly concentrated.” The result is higher premiums and narrower provider networks, which are a root cause of the surprise medical billing problem. it said.
The AMA urged the Biden administration to delay implementation of the rule.
America’s Health Insurance Plans President and CEO Matt Eyles said in a statement that “The Administration’s approach signals a strong commitment to consumer affordability and lower health care spending through an independent dispute resolution process that should encourage more providers to join health plan networks.”
The Biden administration on Thursday issued an interim final rule with comment period to further implement the No Surprises Act – a consumer protection law that helps curb the practice of surprise medical billing.
The rule – which goes into effect Jan. 1 – builds on an interim final rule issued back in July that bans balance billing for emergency services and prohibits out-of-network charges for items and services provided by out-of-network providers at an in-network facility, except if the patient grants consent.
The rule details a process that will take patients out of the middle of payment disputes, provides a transparent process to settle out-of-network (OON) rates between providers and payers, and outlines requirements for health care cost estimates for uninsured (or self-pay) individuals. A payer and provider can initiate a 30-day open negotiation period to determine an out-of-network rate. If the parties can’t reach an agreement after that period, either party can initiate the independent dispute resolution process.
“The parties then may jointly select a certified independent dispute resolution entity to resolve the disputes,” according to a fact sheet on the rule.
After an arbiter is selected, both the payer and provider will submit the amount they believe the service should cost. The arbiter will then select one of the amounts as the out-of-network charge. The arbiter must begin with the presumption that the qualified payment amount, which is the insurance plan’s median contracted rate for the same or similar service in an area, is the appropriate out-of-network charge.
Other consumer protections in the rule include a payment dispute resolution process for uninsured or self-pay individuals. It also adds protections in the external review process so that individuals with job-based or individual health plans can dispute denied payment for certain claims.
We are currently analyzing the rule and will follow up with a full breakdown of the provisions.
The hospital industry blasted HHS on Thursday over an interim final rule laying out the new independent dispute resolution process for the surprise billing law, which hospitals say ignores congressional intent and puts the thumb on the scale in favor of insurers. But insurers and other stakeholders applaud the administration’s direction, saying that by requiring arbitrators to primarily look at the qualifying payment amount (QPA), which is generally the median in-network rate, the rule should limit the use of IDRs and prevent gaming.
The interim final rule — with a comment period – also provides guidance on a similar interim process for self-pay patients who are charged significantly more than the good faith estimate that providers must offer. It sets up a similar process for air ambulance payments. CMS also launched a website for entities interested in becoming a certified IDR entity and will take applications on a rolling basis starting Sept. 30. HHS asks entities to complete applications by Nov. 1 to start by January. Officials said during a press call that they have already been in contact with potential IDR entities and expect about 50 will be certified by next year.
The No Surprises Act, which bans surprise billing for out-of-network emergency and non-emergency services, limits cost-sharing to in-network rates, and creates the new IDR process, passed in Dec. 2020. The legislation came together following a years-long fight between providers and insurers who both wanted patients held harmless from surprise bills but had differing views on how to resolve payment disputes. Insurers wanted out-of-network pay to be based on a benchmark rate, while providers lobbied for an arbitration process. The final legislation included the IDR process and said that arbiters shall consider in their determinations the qualifying payment amount (QPA), which is generally the median in-network rate for a service. Several other factors may also be considered, the law says, including providers’ level of training, quality and patient outcomes, market share for providers and payers, patient acuity, teaching status and prior contracted rates.
After the law was signed, stakeholders began to lobby the administration on how the language should be interpreted.
On one side, insurers, large employers, and some lawmakers argued that the QPA should be the primary factor considered by an arbiter and the other factors could come into play in certain, but rare, instances. They argued that since patient cost-sharing is based on the QPA, and because the Congressional Budget Office assumed that would be used when scoring the bill as a saver, the administration should adopt that interpretation. But others, including provider groups and bipartisan groups of House and Senate lawmakers who had long worked to end surprise billing, disagreed, and urged the administration to make sure all factors included in the law were given equal weight.
The rule out Thursday largely relies on the QPA. “When making a payment determination, certified independent dispute resolution entities must begin with the presumption that the QPA is the appropriate [out-of-network] amount,” the agency explains in a fact sheet. If a party submits additional allowable information, the IDR entity must consider it if it is credible. To deviate from the QPA, the information must clearly show that the value of the item or service is materially different from the QPA. Absent that information, the IDR entity must select the offer closest to the QPA.
Brookings Institution’s Loren Adler, who has been tracking the legislative and rulemaking process, says, from his initial skim of the rule, the rule “appears to delineate a coherent framework to adjudicate out-of-network payment disputes in arbitration, starting with the presumption that the median in-network price is appropriate & deviating only when clear evidence to justify doing so is presented.”
“By setting clear expectations of outcomes through arbitration, the rule should also limit its use and the concomitant administrative costs,” he says.
The insurance lobby AHIP says the rule signals a commitment to consumer affordability that should encourage more providers to join networks. “We are particularly encouraged to see the rules conform to the intent of the No Surprises Act and direct that arbitration awards must begin with a presumption that the appropriate out-of-network reimbursement is the qualified payment amount. This is the right approach to encourage hospitals, health care providers, and health insurance providers to work together and negotiate in good faith. It will also ensure that arbitration does not result in unnecessary premium increases for businesses and hardworking American families.”
The Coalition Against Surprise Medical Billing, which includes insurers, employers, and unions, says while it is still reviewing the regulation, it appreciates that the rules “adhere to and reinforce the statute which calls for the qualifying payment amount (QPA) to be the primary and overriding consideration for final payment determinations as part of the independent dispute resolution (IDR) process.”
“For patients to be protected from abuse and misuse of IDR and to achieve the full cost-savings projected by the Congressional Budget Office, it is essential that the final rules maintain limits on arbitration, “the group adds.
And Senate health committee Chair Patty Murray (D-WA) and House Energy & Commerce Chair Frank Pallone (D-NJ) also applauded the administration for relying primarily on the QPA, which they said was congressional intent.
But the hospital industry strongly disagrees, saying the administration ignores years of work, dismisses congressional intent, and favors insurers over providers and physicians.
“The interim final regulation issued today to implement the No Surprises Act is a total miscue,” Chip Kahn, president and CEO of the Federation of American Hospitals, says. “It inserts a government standard pricing scheme arbitrarily favoring insurers. For two years, hospitals and other stakeholders stood shoulder to shoulder with lawmakers to develop legislation that would protect patients from surprise medical bills and last December, Congress passed a bill with a fair and balanced payment dispute resolution process. This regulation discards all of that hard work, misreads Congressional intent, and essentially puts a thumb on the scale benefiting insurers against providers and will over time reduce patient access.”
“Disappointingly, the Administration’s rule has moved away from Congressional intent and brought new life to harmful proposals that Congress deliberately rejected,” American Hospital Association Executive Vice President Stacey Hughes says. “Today’s rule is a windfall for insurers. The rule unfairly favors insurers to the detriment of hospitals and physicians who actually care for patients. These consumer protections need to be implemented in the right way, and this misses the mark.”
A senior HHS official says staff reviewed the legislation and looked at the results of surprise billing laws across the country and had a robust discussion over the guidance. The official notes the Congressional Budget Office determined the bill would save money, which also played into the strong assumption that QPA is the presumptive factor, and any other factors must be materially different to be considered. This design should prevent inflation and disincentive any gaming.
The official acknowledges that stakeholders were very invested in the decision, and says the department believes the IFR strikes the right balance.
A Biden administration push to make federal health programs more equitable for marginalized populations will likely result in fewer payment models in which providers assume direct financial risk, a top Centers for Medicare & Medicaid Services administrator said.
Speaking at a conference of the National Association of Accountable Care Organizations on Thursday, Jonathan Blum, principal deputy administrator of the CMS, said that as the agency “defines it’s new strategic vision going forward, I would be surprised if CMS defines one of our core measures for outcome being more populations being in full risk-based models.”
Last year, 192 accountable care organizations took “downside” financial risk for cost increases, meaning they would lose revenue and have to reimburse Medicare if their cost of care exceeded agreed-upon thresholds.
Blum’s remarks signal a significant change of direction for the CMS as it moves to reverse or scrap policy directives championed by former CMS Administrator Seema Verma, who served under President Donald Trump. The announcement follows a strategic review of Medicare payment models by the Centers for Medicare and Medicaid Innovation.
Verma had made made a priority of requiring providers to take more financial risk in order to improve the performance of alternative payment models in traditional Medicare. Alternative payment models provide incentive payments to providers for high-quality, cost-efficient care. They’re designed to move fee-for-service Medicare more toward value-based care, in which payments are determined by patient outcomes and cost savings rather than volume of services provided.
Verma argued in 2020 that payment models that provide only incentive payments without the downside “risk” of reduced payment for poor-quality care don’t go far enough to avoid losses for taxpayers.
“Models must incorporate design elements that require participants to have skin in the game,” Verma told the Health Care Payment Learning & Action Network Virtual Summit.
But Blum said “having more beneficiaries in total cost-of-care, fully risk-based models, to us, should not be the end goal. The end goal should be better care, better experience, better life and better overall care system.”
As the CMS focused more on risk-based payment models, quality measures and providing “accountable care,” over the years, it had “collectively lost sight” of its broader purpose of improving patient care, Blum said.
Accountable care organizations, the groups of doctors and hospitals that provide coordinated care through traditional fee-for-service Medicare, saved Medicare nearly $1.9 billion in 2020, the Biden administration reported. ACOs are a major component of traditional Medicare’s move to value-based care.
More than 12.1 million fee-for-service Medicare beneficiaries are now served by providers in ACOs. That’s up from 11.2 million in 2020, according to the CMS, part of the Department of Health and Human Services.
The Centers for Medicare and Medicaid Innovation, which develops Medicare payment models, has told agency leadership that the current roster of alternative payment models “tend to involve those communities that are higher income” and “disproportionately white,” Blum said Thursday.
Liz Fowler, director of the innovation center, has already moved to eliminate some ineffective and overlapping payment models.
Blum said Fowler and her team are working to make sure that future payment models “reflect and better serve, not just those parts of the country that have more resources, that can afford to put in place risk models,” but also those areas that “don’t necessarily have access to the care and support that all of us here today have.”
Current CMS Administrator Chiquita Brooks-LaSure has challenged the agency to reduce health inequities among Medicare and Medicaid populations by expanding opportunities for quality care regardless of personal characteristics like ethnicity, race, gender, geographic location, and economic status. Covid-19 took a disproportionate toll on minority groups, and that experience is helping to guide the Biden administration’s efforts to ensure that those disparities are addressed.
While some research has shown that more provider risk can lead to better patient outcomes, Blum said the increased financial stake also has downsides, like leading to more exaggerated patient diagnoses, or “upcoding.”
He said the risk-based payment models also favor “better capitalized” providers who can afford more risk. That takes away from the agency’s goal of “better serving all beneficiaries equally,” Blum said.
“For models that have more risk, where we truly get better experience, better value, more equity, we’ll celebrate that,” he said. “But where we see risk that brings in some of the downsides of harm, payments that are inappropriate, of skewing the participation towards those that can afford it, that’s a challenge for us.”
“And so I don’t think that CMS will be promoting models that have more risk just for the sake of really having more risk,” he said.
Democratic leaders struggling to satisfy both progressive and moderate factions’ demands are still trying to resolve divisions over scaling back the expansive health care policy wish list in their $3.5 trillion budget reconciliation package.
A smattering of members in both chambers have concerns with key issues ranging from drug pricing to Medicare spending, while Democratic holdouts like Sen. Joe Manchin III of West Virginia and Sen. Kyrsten Sinema of Arizona oppose the legislation’s overall price tag.
House Speaker Nancy Pelosi recently acknowledged that the $3.5 trillion number must come down. The Senate has yet to unveil companion text.
Democrats could try to shorten the duration of programs or focus on certain policies instead of others if the total amount falls. But some Democrats view adding end dates for programs as risky, since it would require lawmakers to extend them in the future.
“We have a tremendous opportunity right now with Democratic majorities in the House and Senate and a Democratic president,” Rep. Lauren Underwood, D-Ill., said on a Wednesday press call with the advocacy group Protect Our Care. “While we have the opportunity to do this work, I think we should take advantage of it because it is an assumption that is made that several years down the line we will have the opportunity to extend.”
Here are the biggest health care issues under consideration.
Letting Medicare negotiate drug prices directly with manufacturers is a white whale for Democrats, who are gunning for the political victory as much as for the $700 billion in potential savings it would offer to fund their remaining health care agenda. But the party is dealing with several defections among members in both chambers that could derail or change the proposals, given Democrats’ slim majorities.
The House bill would set maximum prices for the most expensive drugs under the Medicare Part D prescription drug program and Part B outpatient program at 120 percent of the average paid by other wealthy countries. The bill would also levy an excise tax of up to 95 percent on manufacturers that don’t comply and require drugmakers to pay rebates when they raise prices faster than inflation.
Forecast: Tossup. The outcome depends on how the party wants to define success. House Democrats’ sweeping drug pricing bill is the foundation of discussions, but a recent bill from Rep. Scott Peters, D-Calif., demonstrated the possibility of designing a much narrower law that still achieves some negotiation. Holdout Sinema has also reportedly signaled opposition to negotiation as currently constructed.
The provision is central to the rest of Democrats’ health care agenda, since other spending largely depends on how far lawmakers are willing to go to generate savings from drug pricing measures.
Democrats temporarily expanded tax credits for insurance premiums under the 2010 health care overhaul law as part of the $1.9 trillion COVID-19 aid law in March. The party now wants to extend the more generous credits permanently through the 10-year budget window at a rough cost of around $200 billion.
Households making up to 150 percent of the federal poverty level would receive fully covered insurance on the health law’s exchanges. The legislation would permanently eliminate a cap on subsidy assistance to households making more than 400 percent of the poverty level. Premiums would also be limited to 8.5 percent of a household’s income, making the insurance more affordable for people across the income spectrum.
Forecast: Best bet. Democrats have campaigned on the 2010 law for more than a decade, and retook the House in 2018 amid Republican attempts to repeal it. The provision has the broadest support within the caucus and the most manageable price tag. The expanded coverage would also help reach higher earners who want insurance in the individual market, and who suffer the brunt of the law’s infamous premium increases since they don’t qualify for subsidies.
All but 12 states expanded Medicaid under the 2010 health care law to cover households making up to 138 percent of the poverty level, despite Democrats’ attempts to sway the remaining Republican governors with additional financial incentives. Democrats are now attempting to close the gulf with a lookalike Medicaid program that would be run on the federal level, while covering eligible individuals on the exchanges until the new program is stood up.
House Majority Whip James E. Clyburn, D-S.C., said during a call with the left-leaning Center for American Progress last week that he would be open to a five-year authorization to expand Medicaid to start.
He argued on a separate press call Wednesday that it would be “un-American” for lawmakers to expand other benefits while leaving behind the vulnerable populations in those dozen states.
Forecast: Better odds. The Medicaid expansion is another piece of the 2010 law and important to Democrats’ platform. But questions over drug pricing savings and the slate of competing priorities is throwing the scope and duration of the program into doubt.
Democrats’ short-term solution to include would-be Medicaid recipients on the exchanges is a more expensive way to provide care, since Medicaid is a lower-cost program that pays providers lower rates. The cost is expected to total around $250 billion to $300 billion over 10 years.
The traditional Medicare benefit has gaps, leaving many seniors without services like dental, hearing or vision care. Private Medicare Advantage or Medigap supplemental insurance plans help fill the gap, but lawmakers like Sen. Bernie Sanders, I-Vt., are pushing to cover them under the traditional benefit to ensure broader access.
But spending concerns are at the forefront of the discussion. The Congressional Budget Office previously estimated that adding the benefits would cost as much as $358 billion over 10 years.
Forecast: Longer odds. Spending constraints and the time needed for the Centers for Medicaid and Medicare Services to set up a new benefit forced the House to delay dental coverage under its bill until 2028, with patients responsible for more cost-sharing than under Medicare’s traditional Part B outpatient benefit. Democrats are debating ways to cram the provision into a final package, but further cuts to the scope and duration may be necessary.
The American Dental Association — which opposes a broad Medicare benefit — has also made headway with some skeptical Democrats. Rep. Kurt Schrader, D-Ore., plans to introduce an ADA-backed measure that would tailor dental benefits to low-income enrollees instead.
President Joe Biden is asking Congress for $400 billion over eight years to boost home- and community-based health services. The money would fund historically underpaid care workers’ salaries and boost Medicaid funding for states that take steps to improve home health programs.
Forecast: Tossup. Heavyweights like the Service Employees International Union back the full amount, but the House language only includes $190 billion over 10 years. Some senators are pushing for more, though. And although treating people at home is less expensive than treating them in an institution, the upfront investment is still a major debit on Democrats’ $3.5 trillion scorecard.
The provision is also less flashy than other priorities like expanding insurance, Medicare or Medicaid coverage, where many Democrats are directing the bulk of their efforts. Senate Finance Committee Chair Ron Wyden, D-Ore., a former advocate for the elderly, said he favors shortening the number of years to provide increased funding rather than cutting the topline number.
“If there are changes in the number, topline, I personally — and the caucus will talk about it — I personally would favor a shorter number of years,” Wyden said. “If you have 10,000 people turning 65 every day for years to come, and you have two options — good quality home- and community-based services versus institutional care. That’s not a close call in my book.”
Health agencies’ efforts to combat the Covid-19 pandemic would likely continue in the event of a government shutdown, but other key work—including enrolling patients in clinical trials, drug and disease surveillance, and rulemaking—could come to a halt.
Thursday is the deadline to fund the federal government and avert a shutdown. Both the House and Senate will likely have to pass a short-term spending bill that would need to be signed into law by 11:59 p.m. ET.
The looming shutdown comes as more than 2,000 people die from Covid-19 daily and hospitals in pandemic hot spots consider rationing care. Agencies with public safety functions must assess each activity they conduct to determine if it has a source of funding or falls into an emergency exception that would allow it to continue.
But even when “critical activities” are allowed to continue during a shutdown, “it’s actually very hard to do” those activities because many workers are furloughed or out of action, Joshua Sharfstein, vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, told reporters.
“There are a lot of things that maybe aren’t critical and immediate, but they’re preventing things from becoming critical and immediate,” said Sharfstein, a former second-in-command at the Food and Drug Administration. For example, the CDC was prepared to suspend influenza surveillance during a previous government shutdown, he said.
The Health and Human Service Department would be able to keep a higher percentage of staff compared with 2018, when the last shutdown happened. In 2018, the department furloughed about half its staff—40,845 employees. This year it would furlough about 43%, or about 36,536 people. The HHS has about 3,000 more employees than it did three years ago.
The HHS’ contingency plan is unclear on what types of workers will be furloughed, however, and instead focuses on what work will continue. Here’s a rundown:
Here’s what work would stop if there is a lapse in government funding:
A bipartisan group of 144 House lawmakers plans to unveil their agenda Wednesday for expanding access to mental health care and combating the growing drug epidemic after overdose deaths hit new highs, CQ Roll Call has learned first exclusively.
The group plans to announce its agenda of 66 bills and one resolution during a midday Wednesday news conference. The 48-page bipartisan blueprint outlining the group’s legislative goals includes 12 policy subcategories including prevention, treatment, rural and underserved communities, workforce development, first responders, interdiction, children and families, veterans, prescribing, education, health care access and health parity.
The release of the agenda comes after progress in tackling the drug epidemic ground to a halt during the pandemic.
Over 95,000 people died from drug overdoses in the 12-month period ending in February 2021, the highest ever recorded in a year, according to preliminary Centers for Disease Control and Prevention data. A separate study released last week by the National Institute on Drug Abuse showed that methamphetamine-involved overdose deaths almost tripled from 2015 to 2019.
It also comes as the pandemic has highlighted a number of health disparities in various communities. A National Institutes of Health-supported study published this month showed a 38 percent increase in opioid overdose deaths among non-Hispanic Black individuals in four states from 2018 to 2019. The study of deaths in New York, Massachusetts, Kentucky and Ohio saw opioid overdose deaths for other racial and ethnic groups stay flat or decrease during this time.
An aide for House Majority Leader Steny H. Hoyer declined to make any calendar announcements on when a package would move but said leaders support the work on mental health and addiction.
The bipartisan agenda is spearheaded by the Bipartisan Addiction and Mental Health Task Force formed this year by Reps. Ann McLane Kuster, D-N.H., Brian Fitzpatrick, R-Pa., David Trone, D-Md., and Jaime Herrera Beutler, R-Wash.
The four lawmakers formed the task force by combining and expanding two narrower caucuses focused on opioid addiction to encompass mental health and other drug threats.
Congress has enacted multiple laws to fund prevention and expand treatment of substance use and mental health disorders in recent years.
Previous iterations of the former groups’ agenda formed a basis for material in a 2016 law known as the Comprehensive Addiction and Recovery Act, or CARA, and a 2018 opioid law.
Meanwhile, the Substance Abuse and Mental Health Services Administration announced Tuesday that it would distribute $825 million from the fiscal 2021 omnibus appropriations law to 231 community mental health centers across the country.
The swath of legislation falls under the jurisdiction of multiple committees, though most of the legislation is overseen by the Energy and Commerce or the Judiciary committees. But the agenda also touches on policies under the Ways and Means; Education and Labor; Armed Services; Veterans Affairs; and Oversight and Reform committees.
The bills in the new bipartisan agenda are in different stages of the legislative process and have varying numbers of co-sponsors.
Among the bills is one from Trone and Rep. Steve Womack, R-Ark., that would create a task force to help prevent mental health crises caused by public health emergencies and craft a national strategy based on the impact of the pandemic.
Another by Reps. Mike Thompson, D-Calif., and John Katko, R-N.Y., would ensure Medicare coverage of marriage and family therapists and mental health counselors. The bill would not apply to the skilled nursing facility’s prospective payment system. It has 42 co-sponsors.
Legislation by Rep. Lisa Blunt Rochester, D-Del., would establish two grant programs related to maternal mental health and substance use with a focus on minority groups. It has 50 co-sponsors.
Another bill from Reps. Chrissy Houlahan, D-Pa., and Guy Reschenthaler, R-Pa., would limit copayments for mental health outpatient visits under TRICARE, the military’s health care program. It has four co-sponsors.
Legislation by Reps. Scott Peters, D-Calif., and John Curtis, R-Utah, would designate methamphetamine as an emerging drug threat and would direct the Office of National Drug Control Policy to implement a plan to address the issue. It is already awaiting floor action.
Another bill would authorize grants for law enforcement and corrections agencies to receive mental health crisis training. It is awaiting action from the House Judiciary Committee.
And a bill from Reps. Abigail Spanberger, D-Va., and David B. McKinley, R-W.Va., would authorize a 10 percent set-aside for recovery support within the Substance Abuse Prevention and Treatment Block Grant program. It has four co-sponsors and mirrors language in the president’s budget and House Labor-HHS-Education spending bill.
The agenda also includes legislation that has passed at least one chamber.
That includes a House-passed bill from Reps. Scott Peters, D-Calif., Gus Bilirakis, R-Fla., Ted Deutch, D-Fla., and Fitzpatrick that would fund grants to establish and implement evidence-based suicide awareness and prevention training policies. Another House-passed bill by Rep. Bonnie Watson Coleman, D-N.J., and Katko would establish programs to address racial inequalities in mental health.
The agenda also includes a bill by Reps. Susan Wild, D-Pa., Raja Krishnamoorthi, D-Ill., Judy Chu, D-Calif., and McKinley that has 126 co-sponsors. It would help prevent and reduce mental health conditions and suicide among health care workers. A similar version of the bill passed the Senate by voice vote.
The Senate Finance Committee has also been making inroads into a bipartisan mental health package.
Last week, Finance Chair Ron Wyden, D-Ore., and ranking member Richard M. Burr, R-N.C., sent a letter to stakeholders seeking input for policies related to access to care, behavioral workforce, telehealth, health parity and children’s mental health.
A Senate Democratic aide said the goal is to develop the proposal by year’s end with the hopes of realistically passing legislation next year.
Invalid Email Address